GLP-1 receptor agonists and gastrointestinal effects: Medications such as semaglutide commonly cause nausea, vomiting, and abdominal discomfort (per the Wegovy SmPC), which may be difficult to distinguish from, or may worsen, existing endometriosis-related gastrointestinal symptoms such as bloating and bowel pain
The FDA labels for both semaglutide and tirzepatide address lactation, but the language reveals more about the state of research than the state of risk
It also helps maintain an acidic environment in the gut, which discourages less friendly bacteria
This is where your doctor can provide more information, argue your case with a medical director from the insurance company, or submit a letter detailing why this medication is uniquely necessary for your health
All of these brand-name medications are part of the class of drugs known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs